Detalhe da pesquisa
1.
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study.
Blood Adv;
6(6): 1671-1683, 2022 03 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35073571
2.
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial.
Lancet Haematol;
8(12): e879-e890, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34826411